MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu

MLA

Byung-Chul Lee, et al. “MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.” Frontiers in Immunology, vol. 9, May 2018. EBSCOhost, https://doi.org/10.3389/fimmu.2018.01078.

APA

Byung-Chul Lee, Nari Shin, Jin Young Lee, Insung Kang, Jae-Jun Kim, Seung Eun Lee, Soon Won Choi, Gill A. Webster, & Kyung-Sun Kang. (2018). MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu. Frontiers in Immunology, 9. https://doi.org/10.3389/fimmu.2018.01078

Chicago

Byung-Chul Lee, Nari Shin, Jin Young Lee, Insung Kang, Jae-Jun Kim, Seung Eun Lee, Soon Won Choi, Gill A. Webster, and Kyung-Sun Kang. 2018. “MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.” Frontiers in Immunology 9 (May). doi:10.3389/fimmu.2018.01078.